Search Results 171-180 of 16276 for monoclonal antibody

  1. Blistering (Bullous) Diseases Clinical Trials - Mayo Clinic Research

    Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...

  2. Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer - Mayo Clinic

    Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. Cobimetinib may stop the growth of tumor ...

  3. A Study to Test Sacituzumab Govitecan Therapy in Patients with HER2-Negative Breast Cancer and Brain Metastases - Mayo Clinic

    Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan. Sacituzumab is a form of targeted ...

  4. Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer - Mayo Clinic

    Monoclonal antibodies, such ... No prior treatment with an immune checkpoint inhibitor (anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA4 monoclonal antibody).

  5. Untitled

    In other words, being infected and receiving monoclonal antibodies prevents you from developing a protective immune response. In a sense, we are artificially ...

  6. Mayo Clinic Q&A - Dr. Yi LIn - Multiple myeloma

    We also have since then monoclonal antibody treatments. So, these are again drugs that can be given IV that target certain markers that can show up on plasma ...

  7. Immune Monitoring and Immunotherapy in Myeloma - Mayo Clinic

    The treatments include IMiDs, proteosome inhibitors, chemotherapy, monoclonal antibodies and stem cell transplantation.To c. Participation eligibility.

  8. Mayo Clinic Q & A - Dr. Gregory Poland 12 13 21

    There is now a monoclonal antibody that has been approved under EUA for pre-exposure prevention. In other words, you don't have to wait until you're ...

  9. Margetuximab-cmkb (intravenous route) - Mayo Clinic

    Margetuximab-cmkb is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by ...

  10. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such ... Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin.